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Response
Dear Editors:
We appreciate Dr. Aksoy's response to our paper and
thespecificdataitprovidesregardingthemethodology
usedinhisstudiestocalculate leukemiaincidence and
toestimatebenzene concentrations towhichhiscohort
ofTurkish shoe, slipper, and handbag workers was ex-
posed. Itiswithout questionthatDr. Aksoy'searlyepi-
demiologic observations of the association between
benzene exposure and leukemia are tobe commended.
The major conclusion ofour review, however, was that
the Aksoy studies, as well as some ofthe other avail-
ablebenzene epidemiologicstudies, are notoptimalfor
risk assessment, due primarily tolimitations in quan-
titative exposure information. Given that individual
exposure history data were not apparently available
for workers in the Aksoy study, it remains our judg-
mentthat itprovides a lessuseful basisforthe estima-
tion ofa dose-response relationship thantheRinsky et
al. study that we selected.
SusAN M. BRETT
JOSEPH V. RODRICKS
ENVIRON Corporation
4350 North Fairfax Drive
Arlington, VA 22203
VERNON M. CHINCHILLI
Medical College of Virginia
Other Factors in Leukemia
Dear Editors:
In their interesting paper "Consistencies and Incon-
sistencies Underlyingthe Quantitative Assessment of
Leukemia Risk from Benzene Exposure," Lamm et al.
(1) discussed the results of our paper concerning the
distribution of the types of leukemia in chronic ben-
zene toxicity. According to Lamm et al., 43 (84%) of51
cases of leukemia in my series with chronic benzene
toxicity had acute myelocytic leukemia (AML)(2). Un-
fortunately, there is an important mistake in this cal-
culation. As canbe seeneasilyfromthe paper concern-
ing51 leukemic shoeworkerswithchronicbenzenetox-
icity, only 20 (39.25%) had AML (2). The remaining
were acute lymphoblastic leukemia, 5 shoeworkers
(9.8%); preleukemia, 7 (13.75%); acute erythroleukemia,
10(19.6%); acute myelomonocytic leukemia, 4(7.85%);
acute monocytic leukemia, 1(1.95%); acute undifferen-
tiated leukemia, 1 (1.95%); and chronic myeloid leuke-
mia, 2 (3.9%). On the other hand, it is a matter offact
that there are significant differences concerning the
distribution ofthe types ofleukemia in several studies
on this hematologic malignancy associated with chronic
benzene exposure. In one group, acute types of leuke-
mia predominate, as seen in Vigliani and Forni (3),
Aksoy et al. (2), Infante et al. (4), and Yin et al. (5)
series. Contrary to these, in series of Tareef et al. (6),
Goguel et al. (7), and Browning, who collected series
from the literature (8), chronic types ofleukemia take
the first place in the series ofleukemia due to chronic
benzene toxicity. Considering the above-mentioned
striking differences, we suggested that these findings
may be partly explained by exposure levels, the mode
ofexposure, andthepresence orabsence ofotherhomo-
logs of benzene such as toluene and xylene or other
chemicals (9).
REFERENCES
1. Lamm, S. H., Walters, A. S., Wilson, R., Bryd, D. M., and Grun-
wald, H. Consistencies andinconsistencies underlyingthe quan-
titative assessment of leukemia risk from benzene exposure.
Environ. Health Perspect. 82: 289-297 (1989).
2. Aksoy, M. Malignancies due to occupational exposure to ben-
zene. Am. J. Ind. Med. 7: 395-402 (1985).
3. Vigliani, E. C., and Forni, A. Benzene and leukemia. Environ.
Res. 122-127 (1976).
4. Infante, P. F., Rinsky, R. A., Wagoner, J. K., and Young, R. J.
Leukemia in benzene workers. Lancet ii: 76-78 (1977).
5. Yin, S. N.,Li, G. L.,Tain, F. D., Fu, Z. I., Jin, C., Chen, Y. Z., Luo,
S. J., Ye, P. Z., Zhang, J. Z., Wang, G. C., Zhang, X. C., Wu, H.
N., andZhong, Q. C. Leukemia inbenzene workers. A retrospec-
tive cohort study. Br. J. Ind. Med. 44: 124-128 (1987).
6. Tareef, E. M., Kontchalovskaya, N. M., and Zorina, L. A. Ben-
zene leukemias. Acta Unio Int. Contra Cancrum 19: 751-755
(1963).
7. Goguel, A., Cavigneaux, A, and Bernard, J. Le leukemices ben-
zenique de la region Parisienne, 1950 et 1965. (Etude de 50 ob-
servations). Nov. Rev. Fr. Hemat. 7: 421-441 (1967).
8. Browning, E. Toxicity and Metabolism of Industrial Solvents.
Elsevier, Amsterdam, 1965, pp. 3-65.
9. Aksoy, M. Chronic lymphoid leukaemia and hairy cell leukae-
mia duetochronic exposure tobenzene: report ofthree cases. Br.
J. Haematol. 66: 209-211 (1987).
MUZAFFER AKSOY
Department ofBiology
Marmara Scientific and
Industrial Research Center
R 0. Box 21
41470 Gebze-Kocaeli
Turkey
Response
Dear Editors:
We arepleasedtohearfromthedistinguished Profes-
sor MuzafferAksoy who has contributedgreatly tothe
literature on benzene and leukemia. He has raised a
number of questions concerning our review (1) and
analysis ofthe epidemiological studies ofbenzene and
leukemia. Inourreview, weanalyzedthe setofpublished
population-based studies of leukemia (case count five
or greater) among benzene-exposed workers. We in-
cludedallthestudiesthat(a)indicatedthe sizeanddef-
inition ofthepopulationstudied,(b)commented onthe
characteristics of the benzene exposure, and (c) ap-
peared to have identified all the cases within their
studied population. The second group of studies that